Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the ef... Read More


Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigat... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More


Clinical Trial: Elucidating mechanisms of hostmicrobiome interaction in cholangiocarcinoma development (Japan)

Tokyo, Sept. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062830) titled 'Elucidating mechanisms of hostmicrobiome interaction in cholangiocarcinoma ... Read More


Clinical Trial: Prevalence and Clinical Characteristics of Sarcopenia and Frailty, and the Effectiveness of Multidisciplinary Interventions in Community-Based Internal Medicine Outpatients: A Prospective Cohort Study with a Focus on Diabetes Mellitus (Japan)

Tokyo, Sept. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062829) titled 'A study on muscle mass and physical function in elderly outpatients and the... Read More


Clinical Trial: Multicenter study on the real-world use of an automated pegfilgrastim delivery device and its impact on patient burden, including time and financial toxicity, in Japan (Japan)

Tokyo, Sept. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062774) titled 'Study of an automated pegfilgrastim delivery device and its impact on time ... Read More


Clinical Trial: An Exploratory Study of the Effects of Interocular Suppression and System Characteristics in Monocular Visual Acuity Testing Under Binocular Viewing Using an Autostereoscopic Display (Japan)

Tokyo, Sept. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062767) titled 'A comparative study of monocular visual acuity testing performed with both ... Read More


Clinical Trial: Evaluation of the Effect of the Test Beverage on GLP-1 Secretion (Japan)

Tokyo, Sept. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059003) titled 'Evaluation of the Effect of the Test Beverage on GLP-1 Secretion' on Sept. ... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, Sept. 4 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, Sept. 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More